Janet Rossant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janet Rossant has a total of 846 co-authors. Here are the top co-authors by number of shared publications:
- Bin Gu
Michigan State University
9 shared publications Eszter Posfai
Affiliation Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
8 shared publications- Steffen Biechele
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
8 shared publications Brian J. Cox
Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada
6 shared publications- Amy P. Wong
Hospital for Sick Children
5 shared publications Brian Bradshaw
Affiliation Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
5 shared publications
Latest Publications
- Open Access
- 12 February 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (3) , 102817
Enhancing rigor and reproducibility: Implementing STAR Methods and the ISSCR Standards Checklist at Stem Cell Reports
- 12 February 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (3) , 102817
Open AccessEnhancing rigor and reproducibility: Implementing STAR Methods and the ISSCR Standards Checklist at Stem Cell Reports
- Top Cited PapersOpen Access
- 10 June 2025
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (6) , 102514
Stem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited
- 10 June 2025
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (6) , 102514
Top Cited PapersOpen AccessStem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited
- Open Access
- 19 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (29) , eadl6366
A fibronectin gradient remodels mixed-phase mesoderm
Physical processes ultimately shape tissue during development. Two emerging proposals are that cells migrate toward stiffer tissue (durotaxis) and that the extent of cell rearrangements reflects tissue phase, but it is unclear whether and how these concepts are related. Here, we identify fibronectin-dependent tissue stiffness as a control variable that underlies and unifies these phenomena in vivo. In murine limb bud mesoderm, cells are either caged, move directionally, or intercalate as a function of their location along a stiffness gradient. A modified Landau phase equation that incorporates tissue stiffness accurately predicts cell diffusivity upon loss or gain of fibronectin. Fibronectin is regulated by WNT5A-YAP feedback that controls cell movements, tissue shape, and skeletal pattern. The results identify a key determinant of phase transition and show how fibronectin-dependent directional cell movement emerges in a mixed-phase environment in vivo.
- 19 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (29) , eadl6366
Open AccessA fibronectin gradient remodels mixed-phase mesoderm
Physical processes ultimately shape tissue during development. Two emerging proposals are that cells migrate toward stiffer tissue (durotaxis) and that the extent of cell rearrangements reflects tissue phase, but it is unclear whether and how these concepts are related. Here, we identify fibronectin-dependent tissue stiffness as a control variable that underlies and unifies these phenomena in vivo. In murine limb bud mesoderm, cells are either caged, move directionally, or intercalate as a function of their location along a stiffness gradient. A modified Landau phase equation that incorporates tissue stiffness accurately predicts cell diffusivity upon loss or gain of fibronectin. Fibronectin is regulated by WNT5A-YAP feedback that controls cell movements, tissue shape, and skeletal pattern. The results identify a key determinant of phase transition and show how fibronectin-dependent directional cell movement emerges in a mixed-phase environment in vivo.
- Open Access
- 1 July 2024
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 17 (7)
An Irak1-Mecp2 tandem duplication mouse model for the study of MECP2 duplication syndrome
MECP2 duplication syndrome (MDS) is a neurodevelopmental disorder caused by tandem duplication of the MECP2 locus and its surrounding genes, including IRAK1. Current MDS mouse models involve transgenic expression of MECP2 only, limiting their applicability to the study of the disease. Herein, we show that an efficient and precise CRISPR/Cas9 fusion proximity-based approach can be utilized to generate an Irak1-Mecp2 tandem duplication mouse model (‘Mecp2 Dup’). The Mecp2 Dup mouse model recapitulates the genomic landscape of human MDS by harboring a 160 kb tandem duplication encompassing Mecp2 and Irak1, representing the minimal disease-causing duplication, and the neighboring genes Opn1mw and Tex28. The Mecp2 Dup model exhibits neuro-behavioral abnormalities, and an abnormal immune response to infection not previously observed in other mouse models, possibly owing to Irak1 overexpression. The Mecp2 Dup model thus provides a tool to investigate MDS disease mechanisms and develop potential therapies applicable to patients.
- 1 July 2024
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 17 (7)
Open AccessAn Irak1-Mecp2 tandem duplication mouse model for the study of MECP2 duplication syndrome
MECP2 duplication syndrome (MDS) is a neurodevelopmental disorder caused by tandem duplication of the MECP2 locus and its surrounding genes, including IRAK1. Current MDS mouse models involve transgenic expression of MECP2 only, limiting their applicability to the study of the disease. Herein, we show that an efficient and precise CRISPR/Cas9 fusion proximity-based approach can be utilized to generate an Irak1-Mecp2 tandem duplication mouse model (‘Mecp2 Dup’). The Mecp2 Dup mouse model recapitulates the genomic landscape of human MDS by harboring a 160 kb tandem duplication encompassing Mecp2 and Irak1, representing the minimal disease-causing duplication, and the neighboring genes Opn1mw and Tex28. The Mecp2 Dup model exhibits neuro-behavioral abnormalities, and an abnormal immune response to infection not previously observed in other mouse models, possibly owing to Irak1 overexpression. The Mecp2 Dup model thus provides a tool to investigate MDS disease mechanisms and develop potential therapies applicable to patients.
- Open Access
- 5 February 2024
- Published by Elsevier in Developmental Biology
- Vol. 509, 43-50
Why study human embryo development?
- 5 February 2024
- Published by Elsevier in Developmental Biology
- Vol. 509, 43-50
Open AccessWhy study human embryo development?
- Open Access
- 27 November 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (12) , 1884
Author Correction: Changing the public perception of human embryology
- 27 November 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (12) , 1884
Open AccessAuthor Correction: Changing the public perception of human embryology
- 20 November 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (12) , 1717-1719
Changing the public perception of human embryology
- 20 November 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (12) , 1717-1719
Changing the public perception of human embryology
- Open Access
- 2 October 2023
- Published by Springer Nature in Nature
- Vol. 622 (7983) , 454-456
Why researchers should use human embryo models with caution
- 2 October 2023
- Published by Springer Nature in Nature
- Vol. 622 (7983) , 454-456
Open AccessWhy researchers should use human embryo models with caution
- Open Access
- 10 August 2023
- Published by Springer Nature in Cell Research
- Vol. 33 (10) , 737-738
Studying human embryo development with E-assembloids
- 10 August 2023
- Published by Springer Nature in Cell Research
- Vol. 33 (10) , 737-738
Open AccessStudying human embryo development with E-assembloids